TREM2 and myeloid sarcoma: Triggering receptor expressed on myeloid cells-2 (TREM2), a specific membrane-bound receptor involved in reducing inflammation and promoting phagocytosis, is increased in the CSF of both progressive and relapsing–remitting MS patients (24, 41, 44).